What is the appropriate approach to address potential drug interactions between chemotherapy and supportive medications?

• A. Only check for interactions if the patient reports new symptoms.
• B. Review the full medication list, identify interactions (e.g., allopurinol with 6-mercaptopurine), and adjust therapy accordingly.
• C. Assume interactions are unlikely and proceed without changes.
• D. Stop all supportive medications during chemotherapy.

Answer: (B)

The main idea is to proactively screen for drug interactions by reviewing every medication the patient is taking, not waiting for symptoms to appear. In chemotherapy care, many drugs and supportive medications can interact in ways that increase toxicity or reduce effectiveness. By examining the full list, you can spot known interactions (for example, allopurinol can raise levels of 6-mercaptopurine and increase bone marrow suppression) and adjust therapy before problems arise. This might mean changing the interacting drug, adjusting doses, or choosing safer alternatives and/or implementing closer monitoring. It’s essential to continue providing supportive medications when safe and appropriate, rather than stopping them. Waiting for symptoms, assuming interactions are unlikely, or halting supportive care would jeopardize both safety and treatment success.